William Beverly White
#107,133
Most Influential Person Now
William Beverly White's AcademicInfluence.com Rankings
William Beverly Whitemedical Degrees
Medical
#1366
World Rank
#1696
Historical Rank
Cardiology
#100
World Rank
#102
Historical Rank
Pharmacology
#109
World Rank
#138
Historical Rank
William Beverly Whitephilosophy Degrees
Philosophy
#4386
World Rank
#6877
Historical Rank
Logic
#1852
World Rank
#2706
Historical Rank
Download Badge
Medical Philosophy
William Beverly White's Degrees
- Bachelors Biology University of California, Berkeley
- Doctorate Medicine Stanford University
Similar Degrees You Can Earn
Why Is William Beverly White Influential?
(Suggest an Edit or Addition)William Beverly White's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Alogliptin after acute coronary syndrome in patients with type 2 diabetes. (2013) (2293)
- Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. (2008) (1933)
- Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. (2008) (1333)
- Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. (2014) (923)
- Clinical Practice Guidelines for the Management of Hypertension in the Community (2014) (726)
- Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. (2003) (723)
- Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial (2015) (629)
- A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study. (2002) (547)
- Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association. (2019) (527)
- Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout (2018) (490)
- Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association. (2018) (456)
- Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. (2011) (415)
- Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. (1989) (388)
- Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: a systematic review and meta-analysis. (2014) (371)
- National Standard for Measurement of Resting and Ambulatory Blood Pressures With Automated Sphygmomanometers (1993) (356)
- Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis. (2002) (331)
- Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild-to-moderate hypertension. (1989) (295)
- Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic Hypertension (2003) (291)
- Rapid ventricular filling in left ventricular hypertrophy: II. Pathologic hypertrophy. (1985) (243)
- The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus. (2005) (230)
- Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac. (2002) (222)
- Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial (2001) (218)
- Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. (2015) (216)
- Evaluation of the overall efficacy of the Omron office digital blood pressure HEM‐907 monitor in adults (2001) (214)
- A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism (2011) (203)
- Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials. (2007) (201)
- Effects of the Angiotensin Receptor Blocker Azilsartan Medoxomil Versus Olmesartan and Valsartan on Ambulatory and Clinic Blood Pressure in Patients With Stages 1 and 2 Hypertension (2011) (188)
- Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib. (2003) (186)
- Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial (2019) (179)
- Assessment of four ambulatory blood pressure monitors and measurements by clinicians versus intraarterial blood pressure at rest and during exercise. (1990) (175)
- Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase 2 Trial (2011) (174)
- Heart rate and the rate-pressure product as determinants of cardiovascular risk in patients with hypertension. (1998) (162)
- Effects of Celecoxib on Ambulatory Blood Pressure in Hypertensive Patients on ACE Inhibitors (2002) (154)
- Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate (2001) (152)
- Ambulatory blood-pressure monitoring in clinical practice. (2003) (151)
- When and how to use self (home) and ambulatory blood pressure monitoring. (2008) (145)
- Modulation of suppressor-cell activity by cimetidine in patients with common variable hypogammaglobulinemia. (1985) (135)
- Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension (2015) (132)
- The Comparative Effects of Azilsartan Medoxomil and Olmesartan on Ambulatory and Clinic Blood Pressure (2011) (131)
- Long‐term reproducibility of ambulatory blood pressure (1994) (129)
- Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period. (2004) (127)
- Effects of a New Hormone Therapy, Drospirenone and 17-&bgr;-Estradiol, in Postmenopausal Women With Hypertension (2006) (120)
- Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function. (1993) (120)
- Clinical evaluation of the Colin ABPM 630 at rest and during exercise: an ambulatory blood pressure monitor with gas-powered cuff inflation. (1989) (119)
- Cardiovascular safety of the dipetidyl peptidase‐4 inhibitor alogliptin in type 2 diabetes mellitus (2013) (118)
- COX-2 selective inhibitors in the treatment of osteoarthritis. (2008) (117)
- Effectiveness of the selective aldosterone blocker, eplerenone, in patients with resistant hypertension. (2008) (114)
- Antihypertensive Effects of Drospirenone With 17&bgr;-Estradiol, a Novel Hormone Treatment in Postmenopausal Women With Stage 1 Hypertension (2005) (113)
- Cardiovascular risk factors and small vessel disease of the brain: Blood pressure, white matter lesions, and functional decline in older persons (2016) (111)
- Effects of the Once-Weekly Glucagon-Like Peptide-1 Receptor Agonist Dulaglutide on Ambulatory Blood Pressure and Heart Rate in Patients With Type 2 Diabetes Mellitus (2014) (110)
- Average Daily Blood Pressure, Not Office Blood Pressure, Is Associated With Progression of Cerebrovascular Disease and Cognitive Decline in Older People (2011) (110)
- The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases (2014) (110)
- Graded Blood Pressure Reduction in Hypertensive Outpatients Associated With Use of a Device to Assist With Slow Breathing (2004) (108)
- Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension. (2003) (104)
- Properly defining white coat hypertension. (2002) (103)
- Cardiovascular effects of the cyclooxygenase inhibitors. (2007) (102)
- Comparison of the Novel Angiotensin II Receptor Blocker Azilsartan Medoxomil vs Valsartan by Ambulatory Blood Pressure Monitoring (2011) (102)
- Effects of eplerenone versus losartan in patients with low-renin hypertension. (2005) (101)
- Improved left ventricular filling accompanies reduced left ventricular mass during therapy of essential hypertension. (1986) (101)
- Sustained antihypertensive activity of telmisartan compared with valsartan (2004) (100)
- Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension (2015) (98)
- Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product. (1998) (97)
- Cardiovascular safety in patients receiving roflumilast for the treatment of COPD. (2013) (97)
- Reproducibility of ambulatory blood pressure monitoring in hemodialysis patients. (2000) (96)
- Financial reinforcers for improving medication adherence: findings from a meta-analysis. (2012) (90)
- Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial. (1998) (89)
- The relationship of electronically monitored physical activity to blood pressure, heart rate, and the circadian blood pressure profile. (2000) (89)
- Assessment of patients with office hypertension by 24-hour noninvasive ambulatory blood pressure monitoring. (1986) (89)
- Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics (2000) (87)
- Relevance of blood pressure variation in the circadian onset of cardiovascular events (2003) (82)
- Ambulatory blood pressure monitoring: dippers compared with non-dippers. (2000) (82)
- Usefulness of ambulatory monitoring of blood pressure in assessing antihypertensive therapy. (1989) (82)
- Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women. (2005) (81)
- Effects of the Cyclooxygenase-2 Specific Inhibitor Valdecoxib Versus Nonsteroidal Antiinflammatory Agents and Placebo on Cardiovascular Thrombotic Events in Patients with Arthritis (2004) (79)
- Clinical evaluation of the Accutracker II ambulatory blood pressure monitor: assessment of performance in two countries and comparison with sphygmomanometry and intra-arterial blood pressure at rest and during exercise (1989) (78)
- ASH Position Paper: Home and Ambulatory Blood Pressure Monitoring When and How to Use Self (Home) and Ambulatory Blood Pressure Monitoring (2008) (78)
- Effects of controlled-onset extended-release verapamil on nocturnal blood pressure (dippers versus nondippers). COER-Verapamil Study Group. (1997) (76)
- Importance of blood pressure control over a 24-hour period. (2007) (76)
- Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil. (2012) (75)
- Effects of tyramine administration in Parkinson's disease patients treated with selective MAO‐B inhibitor rasagiline (2006) (74)
- Pediatric Hypertension (2004) (73)
- Noctural dosing of a novel delivery system of verapamil for systemic hypertension. (1995) (70)
- Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate. (1999) (69)
- Pegloticase and Chronic Gout—Reply (2011) (68)
- Circadian blood pressure: clinical implications based on the pathophysiology of its variability. (2007) (68)
- Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia. (2004) (67)
- Effects of Intensive Versus Standard Ambulatory Blood Pressure Control on Cerebrovascular Outcomes in Older People (INFINITY). (2019) (66)
- Blood pressure load and target organ effects in patients with essential hypertension. (1991) (66)
- Nocturnal blood pressure measured by home devices: evidence and perspective for clinical application (2018) (65)
- Early morning hypertension: what does it contribute to overall cardiovascular risk assessment? (2008) (65)
- Hypertension in the Postpartum Woman: Clinical Update for the Hypertension Specialist (2009) (62)
- Azilsartan Medoxomil: A New Angiotensin II Receptor Antagonist for Treatment of Hypertension (2011) (61)
- Selective dopamine-1 agonist therapy in severe hypertension: effects of intravenous fenoldopam. (1988) (60)
- A multicenter evaluation of the A&D TM-2420 ambulatory blood pressure recorder. (1991) (60)
- Azilsartan Medoxomil Plus Chlorthalidone Reduces Blood Pressure More Effectively Than Olmesartan Plus Hydrochlorothiazide in Stage 2 Systolic Hypertension (2012) (60)
- Terminal digit bias in a specialty hypertension faculty practice (2003) (60)
- Sham-Controlled Randomized Trials of Catheter-Based Renal Denervation in Patients With Hypertension. (2019) (60)
- Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting. (2006) (59)
- Regression of left ventricular mass is accompanied by improvement in rapid left ventricular filling following antihypertensive therapy with metoprolol. (1989) (58)
- Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology. (2015) (58)
- A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder. (2012) (57)
- Rapid buildup of brain white matter hyperintensities over 4 years linked to ambulatory blood pressure, mobility, cognition, and depression in old persons. (2013) (57)
- Determinants of the white-coat effect in hypertensive subjects. (1996) (56)
- Smoking-related morbidity and mortality in the cardiovascular setting. (2007) (56)
- Improving the utility of the nocturnal hypertension definition by using absolute sleep blood pressure rather than the "dipping" proportion. (2003) (56)
- Detection, evaluation, and treatment of severe and resistant hypertension: proceedings from an American Society of Hypertension Interactive forum held in Bethesda, MD, U.S.A., October 10th 2013. (2014) (55)
- Controversies in COX-2 selective inhibition. (2002) (55)
- The effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus (2005) (55)
- Transmission of herpes simplex virus type 1 infection in rugby players. (1984) (54)
- Cardiovascular safety of febuxostat and allopurinol in patients with gout and cardiovascular comorbidities. (2012) (54)
- Ambulatory Monitoring and Blood Pressure Variability (1992) (54)
- Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care) (2017) (51)
- Effects of combination therapy with captopril and nifedipine in severe or resistant hypertension (1986) (51)
- Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE Trial (2014) (50)
- Ambulatory blood pressure as a predictor of target organ disease and outcome in the hypertensive patient. (1999) (50)
- Effects of age and 24-hour ambulatory blood pressure on rapid left ventricular filling. (1989) (50)
- Management of Hypertension after Ambulatory Blood Pressure Monitoring (1993) (49)
- Analysis of ambulatory blood pressure data in antihypertensive drug trials. (1991) (49)
- Episodic hypertension secondary to panic disorder. (1986) (49)
- Effects of actual versus arbitrary awake and sleep times on analyses of 24-h blood pressure. (1995) (49)
- Blood pressure effects of the oral contraceptive and postmenopausal hormone therapies. (2011) (49)
- Comparative renal effects of intravenous administration of fenoldopam mesylate and sodium nitroprusside in patients with severe hypertension. (1989) (49)
- Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis. (2009) (48)
- Safety and Tolerability of the Direct Renin Inhibitor Aliskiren: A Pooled Analysis of Clinical Experience in More Than 12,000 Patients With Hypertension (2010) (48)
- Topical anesthesia for laceration repair: tetracaine versus TAC (tetracaine, adrenaline, and cocaine). (1986) (47)
- Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1–2 hypertension (2010) (47)
- Echocardiographic Assessment of Left Ventricular Diastolic Performance in Hypertensive Subjects Correlation with Changes in Left Ventricular Mass (1987) (47)
- The management of hyperkalemia in patients with cardiovascular disease. (2009) (46)
- Effects of chronic nitrendipine on casual (office) and 24‐hour ambulatory blood pressure (1985) (45)
- Lifetime Major Depression is Associated With Coronary Heart Disease in Older Adults: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (2007) (45)
- Intracerebral hemorrhage after carotid endarterectomy associated with ipsilateral fibrinoid necrosis: a consequence of the hyperperfusion syndrome? (1996) (45)
- Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. (2015) (44)
- Role of ambulatory and home blood pressure recording in clinical practice (2009) (44)
- Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising. (2002) (44)
- If only cardiologists did properly measure blood pressure. Blood pressure recordings in daily practice and clinical trials. (2002) (42)
- INtensive versus standard ambulatory blood pressure lowering to prevent functional DeclINe in the ElderlY (INFINITY). (2013) (41)
- Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial (2017) (41)
- Management of hypertension during lactation. (1984) (41)
- Long-Term Reproducibility of Ambulatory Blood Pressure is Superior to Office Blood Pressure in the Very Elderly (2010) (41)
- Defining the problem of treating the patient with hypertension and arthritis pain. (2009) (41)
- Renovascular hypertension in moyamoya syndrome. Therapeutic response to percutaneous transluminal angioplasty. (1988) (41)
- Diurnal blood pressure and blood pressure variability in diabetic normotensive and hypertensive subjects (1992) (41)
- Home blood pressure monitoring: methodology, clinical relevance and practical application: a 2021 position paper by the Working Group on Blood Pressure Monitoring and Cardiovascular Variability of the European Society of Hypertension (2021) (41)
- Blood Pressure–Lowering Efficacy of the Fixed‐Dose Combination of Azilsartan Medoxomil and Chlorthalidone: A Factorial Study (2012) (40)
- A chronotherapeutic approach to the management of hypertension. (1996) (40)
- Impact of smoking cessation on ambulatory blood pressure and heart rate in postmenopausal women. (2001) (40)
- Ambulatory blood pressure monitoring is a useful clinical tool in nephrology. (1997) (40)
- Ambulatory blood pressure monitoring. Hypertensive Diseases Committee, American College of Cardiology. (1994) (40)
- Sleep-disordered breathing and 24-hour blood pressure pattern among older adults. (2009) (40)
- Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril (2013) (39)
- Task force VI: Self-monitoring of the blood pressure. (1999) (39)
- Renal denervation therapy for hypertension: pathways for moving development forward. (2015) (39)
- Methods of blood pressure determination to assess antihypertensive agents: Are casual measurements enough? (1989) (38)
- Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research Consortium. (2015) (38)
- Effects of the Angiotensin II Receptor Blockers Telmisartan vs Valsartan in Combination With Hydrochlorothiazide 25 mg Once Daily for the Treatment of Hypertension (2006) (38)
- Relating cardiovascular risk to out-of-office blood pressure and the importance of controlling blood pressure 24 hours a day. (2008) (38)
- Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region (2005) (38)
- A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men (2020) (37)
- Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators. (1998) (36)
- How well does ambulatory blood pressure predict target-organ disease and clinical outcome in patients with hypertension? (1999) (36)
- Clinical validation of the accutracker, a novel ambulatory blood pressure monitor using R-wave gating for Korotkoff sounds. (1987) (36)
- Evaluation of recent fixed-dose combination therapies in the management of hypertension (2008) (36)
- Management of patients with hypertension and diabetes mellitus: advances in the evidence for intensive treatment. (2000) (35)
- A low-cost reinforcement procedure improves short-term weight loss outcomes. (2011) (35)
- Functional reach of older adults: normative reference values based on new and published data. (2017) (35)
- Ambulatory blood pressure monitoring in the primary care setting: assessment of therapy on the circadian variation of blood pressure from the MICCAT-2 Trial (2005) (35)
- Self-measured home blood pressure in predicting ambulatory hypertension. (2004) (35)
- Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension. Eprosartan Study Group. (1999) (34)
- Ambulatory blood pressure monitoring in patients with panic disorder. (1987) (34)
- Modulation of in vitro synthesis of immunoglobulin and the induction of suppressor activity by therapy with intravenous immune globulin. (1989) (34)
- Assessment of drug-induced increases in blood pressure during drug development: report from the Cardiac Safety Research Consortium. (2013) (33)
- Blood pressure control in the hypertension clinic. (2003) (33)
- The risk of waking-up: impact of the morning surge in blood pressure. (2010) (33)
- History and Justification of a National Blood Pressure Measurement Validated Device Listing (2019) (32)
- Effect of the calcium channel blocker nitrendipine on left ventricular mass in patients with hypertension (1986) (32)
- Multicenter assessment of the QuietTrak ambulatory blood pressure recorder according to the 1992 AAMI guidelines. (1994) (32)
- Lifetime History of Depression, Type 2 Diabetes, and Endothelial Reactivity to Acute Stress in Postmenopausal Women (2012) (32)
- Systolic versus diastolic blood pressure versus pulse pressure (2002) (32)
- Ambulatory blood pressure monitoring in chronic renal disease: technical aspects and clinical relevance (2002) (31)
- Immunoregulatory effects of intravenous immune serum globulin therapy in common variable hypogammaglobulinemia. (1987) (31)
- Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion. (2016) (31)
- Atenolol in Human Plasma and Breast Milk (1984) (30)
- Long-term haemodynamic effects of amlodipine at rest and during exercise in essential hypertension. (1990) (30)
- Safety of Mineralocorticoid Receptor Antagonists in Patients Receiving Hemodialysis (2012) (30)
- Contribution of Ambulatory Blood Pressure Monitoring to the Design and Analysis of Antihypertensive Therapy Trials (1994) (30)
- Intravenous hydralazine for blood pressure management in the hospitalized patient: its use is often unjustified. (2011) (30)
- Clinical usefulness of ambulatory blood pressure monitoring. (1993) (29)
- Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product. (2004) (29)
- Cardiovascular Effects of Incretin-Based Therapies. (2016) (29)
- Chronotherapeutics for Cardiovascular Disease (1998) (29)
- Nocturnal dosing of a novel delivery system of verapamil for systemic hypertension. Verapamil Study Group. (1995) (28)
- The relationships between casual and ambulatory blood pressure measurements and central hemodynamics in essential human hypertension (1994) (28)
- Reinforcing Adherence to Antihypertensive Medications (2015) (28)
- Debate: angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers--a gap in evidence-based medicine. (2003) (28)
- Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial (2008) (27)
- Drospirenone, a New Progestogen, for Postmenopausal Women with Hypertension (2007) (27)
- Ambulatory blood pressure monitoring in the 21st century (2018) (27)
- Pernicious anemia seen initially as orthostatic hypotension. (1981) (27)
- The Rumpel-Leede sign associated with a noninvasive ambulatory blood pressure monitor. (1985) (26)
- Mobility impairment is associated with reduced microstructural integrity of the inferior and superior cerebellar peduncles in elderly with no clinical signs of cerebellar dysfunction☆ (2013) (26)
- Improving Blood Pressure Control: Increase the Dose of Diuretic or Switch to a Fixed‐Dose Angiotensin Receptor Blocker/Diuretic? The Valsartan Hydrochlorothiazide Diuretic for Initial Control and Titration to Achieve Optimal Therapeutic Effect (Val‐DICTATE) Trial (2008) (26)
- Cardiovascular risk, hypertension, and NSAIDs (2007) (26)
- Baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the EXAMINE trial (2016) (26)
- Long-term efficacy and safety of moexipril in the treatment of hypertension. (1994) (25)
- When and how to use self (home) and ambulatory blood pressure monitoring. (2010) (25)
- Improving blood pressure control and clinical outcomes through initial use of combination therapy in stage 2 hypertension (2008) (25)
- High‐sensitivity C‐reactive protein, low‐density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial (2017) (24)
- AJC Editor's consensus: Selective and nonselective nonsteroidal anti-inflammatory drugs and cardiovascular risk. (2010) (24)
- Adhesion molecules, endothelin-1 and lung function in seven population-based cohorts (2013) (24)
- Diurnal blood pressure variability in mineralocorticoid excess syndrome. (1992) (24)
- Safety and Tolerability of the Direct Renin Inhibitor Aliskiren in Combination With Angiotensin Receptor Blockers and Thiazide Diuretics: A Pooled Analysis of Clinical Experience of 12,942 Patients (2011) (24)
- Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy. (2001) (24)
- Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial (2018) (24)
- Aggravated CNS depression with urinary retention secondary to baclofen administration. (1985) (23)
- Centralized adjudication of cardiovascular end points in cardiovascular and noncardiovascular pharmacologic trials: a report from the Cardiac Safety Research Consortium. (2015) (23)
- Effects of the novel norepinephrine prodrug, droxidopa, on ambulatory blood pressure in patients with neurogenic orthostatic hypotension. (2016) (23)
- The use of peridialysis blood pressure and intradialytic blood pressure changes in the prediction of interdialytic blood pressure in haemodialysis patients (2003) (23)
- Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes. (2018) (23)
- Relevance of the trough-to-peak ratio to the 24 h blood pressure load. (1996) (23)
- Advances in Ambulatory Blood Pressure Monitoring for the Evaluation of Antihypertensive Therapy in Research and Practice (2001) (23)
- Effects of azilsartan medoxomil compared with olmesartan and valsartan on ambulatory and clinic blood pressure in patients with type 2 diabetes and prediabetes (2016) (23)
- ALOGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES AFTER ACUTE CORONARY SYNDROMES: HEART FAILURE OUTCOMES AND CARDIOVASCULAR SAFETY IN HEART FAILURE PATIENTS (2014) (22)
- "Inappropriate" physician habits in prescribing oral nifedipine capsules in hospitalized patients. (1996) (22)
- Circadian blood pressure variation in hypertensive patients with primary hyperaldosteronism. (1998) (22)
- Clinical experience with transdermal clonidine in African-American and Hispanic-American patients with hypertension: evaluation from a 12-week prospective, open-label clinical trial in community-based clinics. (1999) (22)
- Drospirenone with 17β-estradiol in the postmenopausal woman with hypertension (2007) (22)
- Cardiovascular risk, hypertension, and NSAIDs (2007) (22)
- Alpha‐methyldopa disposition in mothers with hypertension and in their breast‐fed infants (1985) (22)
- Comparative Antihypertensive Efficacy of Angiotensin Receptor Blocker‐Based Treatment in African‐American and White Patients (2005) (22)
- Multiple Fusobacterium nucleatum liver abscesses. Association with a persistent abnormality in humoral immune function. (1987) (22)
- Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial (2020) (21)
- Long-term safety and efficacy of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertension. (1995) (21)
- Update on the drug treatment of hypertension in patients with cardiovascular disease. (2005) (21)
- The effects of the long‐acting angiotensin–converting enzyme inhibitor cilazapril on casual, exercise, and ambulatory blood pressure (1988) (21)
- Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial (2020) (21)
- Managing Hypertension with Ambulatory Blood Pressure Monitoring (2015) (21)
- Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER Study (2018) (21)
- Cardiovascular effects of pharmacologic therapies for smoking cessation. (2013) (20)
- Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin (2016) (20)
- Evaluation of the 24-hour blood pressure effects of eprosartan in patients with systemic hypertension. (2001) (20)
- Benefits of antihypertensive therapy in older patients with hypertension. (2000) (19)
- Clinical assessment of early morning blood pressure in patients with hypertension. (2007) (19)
- Chronopharmacology of cardiovascular therapy. (2002) (19)
- Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): results in the pre‐specified subgroup with heart failure (2020) (19)
- Alogliptin in Patients with Type 2 Diabetes Receiving Metformin and Sulfonylurea Therapies in the EXAMINE Trial. (2018) (19)
- Review of the state of renal nerve ablation for patients with severe and resistant hypertension. (2013) (19)
- Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure. (1992) (18)
- Transtelephonic Home Blood Pressure to Assess the Monoamine Oxidase-B Inhibitor Rasagiline in Parkinson Disease (2008) (18)
- Long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension. (2016) (18)
- The assessment of portable, non-invasive blood pressure recorders. (1990) (18)
- Average Clinician‐Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE Trial (2018) (18)
- ASH recommendations on the clinical use of home and ambulatory blood pressure monitoring (1995) (18)
- Cardiovascular safety of mirabegron: analysis of an integrated clinical trial database of patients with overactive bladder syndrome. (2018) (18)
- Central hemodynamics and 24-hour blood pressure in obstructive sleep apnea syndrome: effects of corrective surgery. (1990) (18)
- Primary hyperaldosteronism associated with hypertensive emergencies. (2006) (18)
- Ambulatory Blood Pressure Monitoring as an Investigative Tool for Characterizing Resistant Hypertension and Its Rational Treatment (2007) (18)
- Clinical evaluation of the Trimline blood pressure cuffs with the Accutorr PlusTM Monitor (2003) (17)
- Impact of angiotensin receptor blockade in combination with hydrochlorothiazide 25 mg in 2121 patients with stage 1–2 hypertension (2009) (17)
- Income level and inequality as complement to geographical differences in cardiovascular trials. (2019) (17)
- Penile ulcer in heroin abuse: a case report. (1982) (17)
- Comparative acute blood pressure reduction from intravenous fenoldopam mesylate versus sodium nitroprusside in severe systemic hypertension. (1989) (17)
- Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD: A Randomized Noninferiority Trial. (2019) (17)
- Hypertension associated with therapies to treat arthritis and pain. (2004) (17)
- Cardiovascular effects of the selective cyclooxygenase-2 inhibitors. (2007) (16)
- Effects of naproxcinod on blood pressure in patients with osteoarthritis. (2011) (16)
- Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease. (2001) (16)
- Antiarrhythmic drug combinations in the treatment of ventricular tachycardia: Efficacy and electrophysiologic effects: Ross DL, Sze DY, Keefe DL, et al Circulation 66:1205–1210 Dec 1982 (1984) (16)
- Ambulatory blood pressure and target organ involvement in hypertension. (1991) (16)
- The systolic blood pressure versus pulse pressure controversy. (2001) (16)
- Twenty-four-hour blood pressure load as a surrogate end-point in assessing antihypertensive therapy. (1993) (15)
- Thalamic Fractional Anisotropy Predicts Accrual of Cerebral White Matter Damage in Older Subjects with Small-Vessel Disease (2014) (15)
- Cardiorenal Safety of OTC Analgesics (2018) (15)
- Ambulatory Monitoring of Blood Pressure (2001) (15)
- Basal cell carcinoma of the anus: clinical and pathological distinction from cloacogenic carcinoma. (1984) (15)
- Expanding the use of ambulatory blood pressure monitoring for the diagnosis and management of patients with hypertension. (2006) (15)
- Dose dependence of chronic positive inotropic effect of vesnarinone in patients with congestive heart failure due to idiopathic or ischemic cardiomyopathy. (1996) (15)
- An oral calcium antagonist for treatment of hypertensive emergencies (1983) (14)
- Tricenter Assessment of the Efficacy of the ACE Inhibitor, Moexipril, by Ambulatory Blood Pressure Monitoring (1995) (14)
- ASH Scientific Statement Detection, evaluation, and treatment of severe and resistant hypertension Proceedings from an American Society of Hypertension Interactive Forum held in Bethesda, MD, USA, October 10th 2013 (2014) (14)
- Utilizing ambulatory blood pressure recordings to evaluate antihypertensive drug therapy. (1992) (14)
- Comparative efficacy and safety of nisoldipine extended-release (ER) and amlodipine (CESNA-III study) in African American patients with hypertension. (2003) (14)
- Systemic herpes simplex virus type 2 infection. Proctitis, urinary retention, arthralgias, and meningitis in the absence of primary mucocutaneous lesions. (1984) (14)
- Evaluating Cardiovascular Safety of Novel Therapeutic Agents for the Treatment of Type 2 Diabetes Mellitus (2014) (14)
- The Role of Ambulatory Monitoring of the Blood Pressure for Assessment of Antihypertensive Agents (1992) (14)
- Timed mobility: description of measurement, performance, and dimensionality among older adults (2018) (14)
- Hydralazine hoarseness. A new appearance of drug-induced systemic lupus erythematosus. (1984) (14)
- Longitudinal microstructural changes of cerebral white matter and their association with mobility performance in older persons (2018) (14)
- Telmisartan/Hydrochlorothiazide (2012) (13)
- Cardiovascular Safety of Droxidopa in Patients With Symptomatic Neurogenic Orthostatic Hypotension. (2017) (13)
- Acute psychotic behavior associated with atenolol. (1983) (13)
- Blood pressure destabilization on nonsteroidal antiinflammatory agents: acetaminophen exposed? (2010) (13)
- Importance of aggressive blood pressure lowering when it may matter most. (2007) (13)
- Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology. (2015) (13)
- Is It Possible to Manage Hypertension and Evaluate Therapy Without Ambulatory Blood Pressure Monitoring? (2012) (13)
- M001 Hyperaldosteronism is a common cause of secondary hypertension missed by primary care physicians and associated with normokalemia (1998) (12)
- Effects of combining azilsartan medoxomil with amlodipine in patients with stage 2 hypertension (2014) (12)
- Cardiovascular Safety of the β3‐Adrenoceptor Agonist Mirabegron and the Antimuscarinic Agent Solifenacin in the SYNERGY Trial (2018) (12)
- Effects of the chronotherapeutic delivery of verapamil on circadian blood pressure in African-American patients with hypertension. (1998) (12)
- Accelerated hypertension with encephalopathy due to an isolated dissection of a renal artery branch vessel. (1994) (12)
- Relationships among clinic, home, and ambulatory blood pressures with small vessel disease of the brain and functional status in older people with hypertension (2018) (12)
- Red cell distribution width in patients with diabetes and myocardial infarction: An analysis from the EXAMINE trial (2021) (12)
- USEFULNESS OF MOEXIPRIL AND HYDROCHLOROTHIAZIDE IN MODERATELY SEVERE ESSENTIAL HYPERTENSION (1997) (12)
- Integrated safety studies of the urate reabsorption inhibitor lesinurad in treatment of gout (2018) (12)
- Hypotension with postural syncope secondary to the combination of chlorpromazine and captopril. (1986) (12)
- Alpha-methyldopa disposition in mothers with hypertension and in their breast-fed infants. (1985) (12)
- Effects of chronic cetamolol therapy on resting, ambulatory, and exercise blood pressure and heart rate (1986) (12)
- Passive transfer of antibodies to human T-cell lymphotropic virus type III in patients receiving high-dose intravenous immunoglobulin. (1986) (11)
- Relation of Serum and Urine Renal Biomarkers to Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndromes (From the EXAMINE Trial). (2019) (11)
- Clinical outcome of a mandatory formulary switch for dihydropyridine calcium channel blocker therapy at a Veteran's Administration Medical Center. (1996) (11)
- Advances in Ambulatory Blood Pressure Monitoring for the Evaluation of Antihypertensive Therapy (2007) (11)
- Treatment of Benign Prostatic Hyperplasia in Hypertensive Men (2005) (11)
- Should the Concentration of Vitamin D Be Measured in All Patients With Hypertension? (2010) (11)
- OR-52: Comparison of selective aldosterone blockade versus calcium antagonism on blood pressure, vascular compliance, and microalbuminuria in systolic hypertension in older people (2002) (11)
- Predicting hypertensive heart disease via non-invasive methodology: relationship between ambulatory blood pressure and cardiac indices derived by echocardiography and radionuclide ventriculography. (1990) (11)
- Angiotensin‐Converting Enzyme Inhibitors in the Treatment of Hypertension: An Update (2007) (11)
- COMPARISON OF ANTIHYPERTENSIVE EFFICACY OF THE NEW ANGIOTENSIN RECEPTOR BLOCKER AZILSARTAN MEDOXOMIL WITH RAMIPRIL: PP.16.112 (2010) (10)
- Orthostatic hypotension and pernicious anemia. (1987) (10)
- Abnormalities in blood pressure regulation in a patient with Parkinson's disease. (2003) (10)
- Comparative Effects of Telmisartan in the Treatment of Hypertension (2000) (10)
- Rapid atrial fibrillation associated with trazodone hydrochloride. (1985) (10)
- Determinants of left atrial size in patients with newly diagnosed untreated hypertension (2003) (10)
- Early and Chronic Dipeptidyl‐Peptidase‐IV Inhibition and Cardiovascular Events in Patients With Type 2 Diabetes Mellitus After an Acute Coronary Syndrome: A Landmark Analysis of the EXAMINE Trial (2018) (10)
- Gout, Xanthine Oxidase Inhibition, and Cardiovascular Outcomes (2018) (10)
- Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation (2018) (10)
- Effects of the hormone therapy, drospirenone and 17-beta estradiol, on early morning blood pressure in postmenopausal women with hypertension. (2008) (9)
- The effects of the spleen tyrosine kinase inhibitor fostamatinib on ambulatory blood pressure in patients with active rheumatoid arthritis: results of the OSKIRA-ABPM (ambulatory blood pressure monitoring) randomized trial. (2014) (9)
- BLOCKADE OF ALDOSTERONE PRODUCTION AS A NOVEL APPROACH TO THE MANAGEMENT OF HIGH BLOOD PRESSURE: EFFICACY AND TOLERABILITY OF THE ALDOSTERONE SYNTHASE INHIBITOR LCI699 IN PATIENTS WITH STAGE 1-2 HYPERTENSION (2010) (9)
- Clinical trial experience around the globe: Focus on calcium‐channel blockers (2003) (9)
- Psoriasiform cutaneous eruptions induced by cetamolol hydrochloride. (1986) (9)
- Accuracy and analysis of ambulatory blood pressure monitoring data (1992) (9)
- Novel Approaches for the Treatment of the Patient with Resistant Hypertension: Renal Nerve Ablation (2013) (9)
- Current Concepts of Pharmacotherapy in Hypertension - Chronotherapeutics and Its Role in the Treatment of Hypertension and Cardiovascular Disease. (2000) (9)
- Unilateral renal artery stenosis seen initially as severe and symptomatic hypokalemia. Pathophysiologic assessment and effects of surgical revascularization. (1993) (9)
- Out-of-Office Blood Pressure Monitoring (2016) (9)
- Is white-coat hypertension innocent or detrimental? (1999) (9)
- Nitrendipine in human plasma and breast milk (2004) (8)
- ANTIHYPERTENSIVE EFFICACY OF THE NOVEL ANGIOTENSIN RECEPTOR BLOCKER AZILSARTAN MEDOXOMIL IN COMBINATION WITH AMLODIPINE: PP.16.99 (2010) (8)
- Clinical utility of ambulatory blood pressure: perspectives for national insurance coverage (2002) (8)
- Evaluation of the Migraine Treatment Sumatriptan/Naproxen Sodium on Blood Pressure Following Long‐Term Administration (2011) (8)
- Effects of the oral testosterone undecanoate Kyzatrex™ on ambulatory blood pressure in hypogonadal men (2021) (8)
- Severe delayed inflammatory reactions from injected insulin. Association with cell-mediated immunity. (1983) (8)
- Diagnostic evaluation: Ambulatory blood pressure monitoring in clinical hypertension management. (2014) (8)
- A strategy utilizing ambulatory monitoring and home and clinic blood pressure measurements to optimize the safety evaluation of noncardiovascular drugs with potential for hemodynamic effects: a report from the SYNERGY trial (2018) (8)
- Ambulatory blood pressure monitoring during exercise and physical activity. (1991) (8)
- Evaluation of the angiotensin II receptor blocker azilsartan medoxomil in African‐American patients with hypertension (2017) (8)
- P-255: Ambulatory blood pressure monitoring in the primary care setting: Assessment of therapy on circadian variation of blood pressure from the MICCAT-2 trial (2005) (8)
- Erratum: The effects of cyclooxygenase-2 [COX-2] inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus (Archives of Internal Medicine (2005) 165 (161-168)) (2005) (8)
- Influence of sex, age and race on coronary and heart failure events in patients with diabetes and post-acute coronary syndrome (2021) (8)
- Impact of the daily blood pressure load on the development of hypertensive heart disease. (1992) (8)
- Cardiovascular safety of therapies for type 2 diabetes (2017) (8)
- Usefulness of ambulatory blood pressure monitoring to assess the melanocortin receptor agonist bremelanotide (2016) (8)
- Coadministered vardenafil (for erectile dysfunction) and tamsulosin do not induce hypotension in patients with benign prostatic hypertrophy (2004) (8)
- IDENTIFICATION OF THE MICROBIAL COMMUNITIES ASSOCIATED WITH ROOTS IN LAVA TUBES IN NEW MEXICO AND HAWAI`I (2009) (7)
- Long-term haemodynamic effects of amlodipine at rest and during exercise in essential hypertension. (1990) (7)
- Incidental Finding of Intense Thyroid Radiogallium Activity During Febrile Illness (1985) (7)
- "The nighttime might be the right time" for cardiovascular event prediction. (2012) (7)
- Rationale for Establishing a Mechanism to Increase Reimbursement to Hypertension Specialists (2013) (7)
- Effects of a State‐ and Use‐Dependent Nav1.7 Channel Blocker on Ambulatory Blood Pressure: A Randomized, Controlled Crossover Study (2018) (7)
- Utility of ambulatory blood pressure monitoring for the management of hypertension (2017) (7)
- The importance of the clinical observer in the development of a white-coat effect in African–American patients with hypertension (2008) (7)
- Assessment of ambulatory blood pressure recorders: accuracy and clinical performance. (1991) (7)
- Comparison of the effects of aliskiren/valsartan in combination versus valsartan alone in patients with stage 2 hypertension. (2012) (7)
- Effects of metoprolol succinate extended release vs. amlodipine besylate on the blood pressure, heart rate, and the rate-pressure product in patients with hypertension. (2008) (7)
- An Effectiveness Study Comparing Algorithm‐Based Antihypertensive Therapy With Previous Treatments Using Conventional and Ambulatory Blood Pressure Measurements (2006) (7)
- Effects of a Novel Oral Testosterone Undecanoate on Ambulatory Blood Pressure in Hypogonadal Men (2021) (7)
- Ischemic cardiac outcomes and hospitalizations according to prior macrovascular disease status in patients with type 2 diabetes and recent acute coronary syndrome from the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care trial. (2016) (7)
- Ambulatory Monitoring of Blood Pressure: Devices, Analysis, and Clinical Utility (2000) (7)
- Ejaculatory failure and urinary dysfunction secondary to labetalol. (1988) (7)
- Rofecoxib, but not celecoxib or naproxen, increases mean 24-hour systolic blood pressure in treated hypertensive patients with osteoarthritis and type 2 diabetes mellitus (2003) (6)
- Ambulatory blood pressure monitoring in the evaluation of hypertension therapy. (1995) (6)
- Olecranon bursitis associated with 24-hour ambulatory blood pressure monitoring. (1994) (6)
- 873: Cardiovascular Safety of Vardenafil in Patients on Antihypertensive Therapies and Alpha-Blockers: Findings From Analyses of 17 Placebo-Controlled Clinical Trials (2005) (6)
- Changes in plasma renin match the antihypertensive effects of aliskiren in patients with hypertension: Placebo/irbesartan-controlled trial with the orally active renin inhibitor aliskiren (2005) (6)
- Impact of the Norepinephrine Prodrug Droxidopa on the QTc Interval in Healthy Individuals (2017) (6)
- Efficacy of azilsartan medoxomil with chlorthalidone in hypertension (2014) (6)
- "Translational" medicine: transforming SPRINT findings into clinical practice. (2016) (6)
- Timing of randomization after an acute coronary syndrome in patients with type 2 diabetes mellitus. (2020) (5)
- Severe, accelerated postpartum hypertension associated with hyperthyroxinaemia. Case report (1986) (5)
- General cardiology: abstractCardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib☆ (2003) (5)
- Blood pressure control and edema rates in older patients with hypertension and osteoarthritis following treatment with COX-2 specific inhibitors (2002) (5)
- Once-daily effects of the angiotensin receptor blocker, eprosartan on 24-hour blood pressure in patients with systemic hypertension (1999) (5)
- A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension (2018) (5)
- Successful treatment of a monoamine oxidase inhibitor-tyramine hypertensive emergency with intravenous labetalol. (1985) (5)
- Comparison of Effectiveness of Azilsartan Medoxomil and Olmesartan in Blacks Versus Whites With Systemic Hypertension. (2018) (5)
- Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril–Hydrochlorothiazide Hypertension Trial (2008) (5)
- Effects of Telmisartan with Hydrochlorothiazide versus Valsartan with Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension (2012) (5)
- Committee of the Council for High Blood Pressure Research Statement From the American Heart Association Professional Education Resistant Hypertension: Diagnosis, Evaluation, and Treatment. A Scientific (2008) (5)
- The cyclooxygenase-2 specific inhibitor valdecoxib is not associated with an increased risk of cardiovascular thrombotic events in arthritis patients (2003) (5)
- Renin-Angiotensin Aldosterone System and Hypertension: Current Approaches and Future Directions (2015) (5)
- Propranolol and white rabbits. (1982) (5)
- Ambulatory blood pressure monitoring should be included in the National Health and Nutritional Examination Survey (NHANES). (2012) (5)
- Rofecoxib but not celecoxib increases systolic blood pressure in hypertensive patients treated with ace inhibitors and beta-blockers (2002) (5)
- Angiotensin‐Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers: Is There a Difference in Response and Any Advantage to Using Them Together in the Treatment of Hypertension? (2008) (5)
- The use of an antihistamine-decongestant in conjunction with an anti-infective drug in the treatment of acute otitis media (1983) (5)
- Effectiveness of nonsteroidal mineralocorticoid receptor antagonists in patients with diabetic kidney disease (2022) (5)
- P-46: The importance of the clinical observer in the development of a white-coat effect in African-American patients with hypertension (2004) (5)
- OR-25: Rofecoxib, but not celecoxib or naproxen, increases mean 24-hour systolic blood pressure: Results of a randomized double blind controlled trial in treated hypertensive patients with osteoarthritis (OA) and type 2 diabetes mellitus (2003) (5)
- The editor's roundtable: effect of nonsteroidal anti-inflammatory drugs on blood pressure. (2010) (5)
- Circadian variation of blood pressure. (1996) (5)
- Exposure to Racial Discrimination and Ambulatory Blood Pressure in Women with Type 2 Diabetes. (2016) (5)
- Circadian variation of blood pressure and the assessment of antihypertensive therapy. (1999) (5)
- Ambulatory blood pressure monitoring in current clinical practice and research. (1995) (5)
- Painless postpartum thyroiditis seen initially as severe hypertension. (1984) (4)
- SAT0094 Celecoxib does not increase the risk of cardiac failure, oedema, or hypertension compared to nsaids: results from success 1, a double blind, randomised trial in 13,274 oa patients (2001) (4)
- Leadership Message: American Society of Hypertension–Designated Centers of Excellence: A New Initiative (2011) (4)
- CARDIOVASCULAR EVENTS IN CLINICAL TRIALS INVOLVING OVER 41,000 PATIENTS EVALUATING THE CYCLOOXYGENASE-2 INHIBITOR CELECOXIB: 66 (2006) (4)
- Pharmacologic Agents in the Management of Hypertension—Nisoldipine Coat‐Core (2007) (4)
- White's 1853 Leeds and the clothing districts of Yorkshire : a reprint of the 1853 issue of Directory and gazetteer of Leeds, Bradford, Halifax, Huddersfield, Wakefield and the whole of the clothing districts of Yorkshire (1969) (4)
- Measurement of long-term hemodynamic changes and the use of 24-hour blood pressure monitoring to evaluate treatment. (1994) (4)
- Angiotensin II and trials of cardiovascular outcomes. Discussion (2002) (4)
- CLINICAL HYPERTENSION AND VASCULAR DISEASES (2005) (4)
- 558 AZILSARTAN MEDOXOMIL VS OLMESARTAN AND VALSARTAN: EFFECTS ON AMBULATORY AND CLINIC BP IN HYPERTENSIVE BLACK PATIENTS (2012) (4)
- Ambulatory blood pressure monitoring in cerebrovascular and retinal vascular disease. (1997) (4)
- THE NITRIC OXIDE DONATOR NAPROXCINOD HAS BLOOD PRESSURE EFFECTS SIMILAR TO PLACEBO IN PATIENTS ON RENIN-ANGIOTENSIN SYSTEM BLOCKERS: 9D.02 (2010) (4)
- AHA / ACC / ASH Scientific Statement Treatment of Hypertension in Patients With Coronary Artery Disease (2015) (4)
- The potential role of nitric oxide in cardiovascular safety when treating osteoarthritis in patients with hypertension. Introduction. (2009) (4)
- Effects of vibegron on ambulatory blood pressure in patients with overactive bladder: results from a double-blind, placebo-controlled trial (2021) (4)
- Patiromer and Spironolactone in Resistant Hypertension and Advanced CKD: Analysis of the Randomized AMBER Trial. (2021) (4)
- RESULTS OF A NOVEL ANGIOTENSIN RECEPTOR BLOCKER, AZILSARTAN MEDOXOMIL, IN PATIENTS WITH PRIMARY HYPERTENSION: 9A.01 (2010) (4)
- β-Blockers in neurologic practice (2011) (4)
- Drugs for cough and cold symptoms in hypertensive patients. (1985) (4)
- THE NEW ANGIOTENSIN RECEPTOR BLOCKER AZILSARTAN MEDOXOMIL HAS SIGNIFICANTLY GREATER 24-HOUR BLOOD PRESSURE LOWERING EFFICACY TO BOTH OLMESARTAN AND VALSARTAN: 9D.05 (2010) (4)
- Cardiovascular events and COX-2 inhibitors. (2001) (4)
- Erythroderma with spongiotic dermatitis. Association with common variable hypogammaglobulinemia. (1985) (4)
- Beta blockers with intrinsic sympathomimetic activity. (1985) (4)
- Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinic BP in 400 patients with systemic hypertension: results from a pivotal multinational trial (2002) (3)
- Assessing hypertension management: the role of 24-hour blood pressure monitoring. (1993) (3)
- Experimental augmentation of cerebral blood flow by mannitol in epidural intracranial masses: Dempsey RJ, Kindt GW J Trauma 22:449–454 Jun 1982 (1983) (3)
- Evaluation of Serum Urate Levels and the Clinical Manifestation of Gout with Cardiovascular Mortality from the CARES Trial. (2022) (3)
- Clinical factors associated with significant coronary lesions following out‐of‐hospital cardiac arrest (2021) (3)
- Clinician's Corner. (1996) (3)
- P-452: Effects of the COX-2 specific inhibitor celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibition (2001) (3)
- The riskiest time for the brain: could the nighttime be the right time for intervention? (2007) (3)
- Clinical Experience with Labetalol and Enalapril in Combination in Patients with Severe Essential and Renovascular Hypertension (1988) (3)
- P-254: Telmisartan plus hydrochlorothiazide (80/25 mg) has a greater antihypertensive effect than valsartan plus hydrochlorothiazide (160/25 mg) in patients with stage 1 and 2 hypertension (2005) (3)
- The potential role of nitric oxide in cardiovascular safety when treating patients with osteoarthritis and hypertension: a moderated panel discussion. (2009) (3)
- COX-2 selective inhibitors and heart health. (2005) (3)
- Alternatives to splenectomy in adults after trauma: Millikan JS, Moore EE, Moore GE, et al Am J Surg 144:711–716 Dec 1982 (1983) (3)
- Thomas G. Pickering 1940–2009 (2009) (3)
- P-265: Comparison of nocturnal dosing of diltiazem er and ramipril on early morning blood pressure, heart rate and the rate-pressure product (2003) (3)
- L010: Trans-telephonic home blood pressure monitoring is an effective tool in the management of hypertensive patients (2000) (3)
- Severe and refractory hypertension in a young woman. (2016) (3)
- Treatment priorities in combined blunt abdominal and aortic trauma: Borman KR, Aurbakken CM, Weigelt JA Am J Surg 144: 728–731 Dec 1982 (1983) (3)
- The emerging role of chronotherapeutics in managing hypertension. Panel discussion. (1996) (3)
- Vascular disease and the renin-angiotensin system in the patient with hypertension. (2000) (3)
- The evaluation of antihypertensive therapy using 24-h ambulatory monitoring technology. (2000) (3)
- ACE INHIBITOR USE AND MAJOR CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES TREATED WITH THE DPP-4 INHIBITOR ALOGLIPTIN (2015) (2)
- P-498: Blood pressure response of eplerenone according to baseline characteristics (2003) (2)
- Circadian heart rate response to chronotherapy versus conventional therapy in patients with hypertension and myocardial ischemia (2000) (2)
- TCT-87 Non-invasive Renal Denervation Study Using Externally Delivered Focused Ultrasound in Severe Resistant Hypertension: 1 Year Follow up Results (2015) (2)
- Hypertension management: differing points of view: ambulatory blood pressure monitoring for every hypertensive patient: it's about time!: the argument against. (2004) (2)
- Home blood pressure monitoring as an intervention to control hypertension: comment on "Home blood pressure management and improved blood pressure control". (2011) (2)
- Management of Hypertension in Older Patients With Arthritis (2005) (2)
- Evaluation of the overall system precision of the Welch-Allyn transtelephonic home blood pressure monitor in adults with Parkinson's disease (2002) (2)
- Cardiovascular aspects of prostaglandin inhibition: Focus on the COX-2 specific inhibitors (2003) (2)
- In Memoriam: Thomas G. Pickering 1940-2009. (2009) (2)
- P-447: Blood pressure control and edema rates in older patients with systolic hypertension and osteoarthritis following treatment with COX-2 specific inhibitors (2001) (2)
- NEW ANGIOTENSIN II RECEPTOR BLOCKER AZILSARTAN MEDOXOMIL: COMPARISON TO VALSARTAN: PP.16.88 (2010) (2)
- Effects of the novel melanocortin receptor agonist bremelanotide on ambulatory blood pressure and heart rate in women with sexual dysfunction (2014) (2)
- Drospirenone and 17-&bgr; Estradiol Reduces 24-Hour Blood Pressure in Postmenopausal Women With Hypertension (2006) (2)
- P-446: Hypertension and edema rates in 6,717 patients for the new COX-2 inhibitor, valdecoxib versus the conventional, nonselective NSAIDs and placebo (2003) (2)
- Predictors of blood pressure control in the convince trial (2004) (2)
- Novel therapy in the management of hypertension: Preliminary experience with renin inhibitors (2005) (2)
- Total cardiovascular events analysis of the EXAMINE trial in patients with type 2 diabetes and recent acute coronary syndrome (2018) (2)
- Abstract 17360: Evaluating Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes After an Acute Coronary Syndrome: Insights From the EXAMINE Trial (2017) (2)
- Cyclooxygenase-2 inhibitors and cardiovascular thromboembolic events. (2002) (2)
- O-45: Trans-telephonic home blood pressure strongly correlates to ambulatory blood pressure but is significantly lower than awake values (2001) (2)
- Methodological and Regulatory Considerations for Updated Guidance on the Pressor Effects of Drugs (2020) (2)
- Hematuria after blunt trauma: When is pyelography useful? (1983) (2)
- AVERAGE DAILY BLOOD PRESSURE, NOT OFFICE BLOOD PRESSURE, DETERMINES THE PROGRESSION OF CEREBROVASCULAR DISEASE AND FUNCTIONAL DECLINE IN OLDER PERSONS (2011) (2)
- Cardiovascular Safety of Febuxostat. (2018) (2)
- 838-2 Rofecoxib increases cardiovascular events in arthritis patients but celecoxib and nonspecific nonsteroidal anti-inflammatory drugs do not: Results from a large new England health care claims database (2004) (2)
- Hypertension: Pathophysiology, Diagnosis, and Management (1991) (2)
- C17 - Assessment of the angiotensin II receptor antagonist, eprosartan, by office and ambulatory BP monitoring (1995) (2)
- Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension (2003) (2)
- Major Adverse Cardiovascular Events In Patients With Chronic Obstructive Pulmonary Disease: Analysis Of 14 Pooled Roflumilast Studies (2011) (2)
- G15Long-term followup of untreated white-coat hypertensive patients. (1995) (2)
- Assessment of blood collection systems for the high performance liquid chromatography measurement of propranolol. (1985) (2)
- Cardiovascular events and COX-2 inhibitors. Authors' reply (2001) (2)
- Evaluation of the 24 h effects of the angiotensin II receptor blockers: means to improve cardiovascular outcomes? (2003) (2)
- Hypertension: Antihypertensive class matters for combination therapy (2010) (2)
- G18 - Age, duration of hypertension and pulse pressure are determinants of the white-coat effect in hypertensive patients (1995) (2)
- Radiating abdominal pain and hypertension. (2009) (2)
- Clinical Precision in the Management of Hypertension: Improving Upon the "One-Size-Fits-All" Approach. (2018) (2)
- Ambulatory blood pressure monitoring: technique and application in the study of cardiac dysfunction and congestive heart failure. (2001) (2)
- G17 – Impact of using actual versus arbitrary awake and sleep times on analyses of 24-hour ambulatory blood pressure (1995) (2)
- Patient Characteristics Associated With Resistant Hypertension Older age High baseline blood pressure Obesity Excessive dietary salt ingestion Chronic kidney disease Diabetes Left ventricular hypertrophy Black race Female sex (2008) (2)
- White-Coat Hypertension (2005) (1)
- Leuven consensus conference on ambulatory BP monitoring task force IV: self-monitoring of the blood pressure (2000) (1)
- Management of Hypertension in Athletes (2018) (1)
- Clinical Trials With Calcium Antagonists in Older Patients With Hypertension (2005) (1)
- C001 Nondippers with essential hypertension have greater sleep activity than dippers (1998) (1)
- Outcomes with physician's choice of initial drug in convince (2004) (1)
- Ambulatory Monitoring of Blood Pressure: An Overview of Devices, Analyses, and Clinical Utility (2016) (1)
- Radiogallium imaging in primary renal candidiasis. (1983) (1)
- Blood Pressure Monitoring enters its second decade of publication (2006) (1)
- Neuroretinitis following salvarsan injection (1921) (1)
- A New Era of Renal Denervation Trials for Patients With Hypertension? (2018) (1)
- External validation and extension of the TIMI risk score for heart failure in diabetes for patients with recent acute coronary syndrome: An analysis of the EXAMINE trial (2022) (1)
- Efficacy and tolerability of nebivolol added to RAAS inhibitors (2015) (1)
- Spironolactone for resistant hypertension in advanced chronic kidney disease-red, amber or green? (2020) (1)
- Intramural hematoma of the aorta as a presenting sign of accelerated hypertension. (2012) (1)
- Cardiovascular risk and ambulatory blood pressure (1999) (1)
- Effects of the norepinephrine prodrug droxidopa - a novel treatment for neurogenic orthostatic hypotension - on cardiac repolarization (2015) (1)
- Calculation of Trough-to-Peak Ratio (1996) (1)
- Blood and Urine Biomarkers Predicting Worsening Kidney Function in Patients with Type 2 Diabetes Post-Acute Coronary Syndrome: An Analysis from the EXAMINE Trial (2021) (1)
- Peritoneal lavage and angiography in the management of patients with pelvic fractures: Gilliland MG, Ward RE, Flynn TC, et al Am J Surg 14:744–747 Dec 1982 (1983) (1)
- A015: Extreme dipping — a definitional dilemma. (1999) (1)
- Ambulatory Blood Pressure Monitoring in Older Persons (2016) (1)
- Left Ventricular Hypertrophy and Diastolic Dysfunction (2001) (1)
- Devices for Home Blood Pressure Monitoring (2019) (1)
- The Effects of Nebivolol-Valsartan Single-Pill Combinations in Reducing Blood Pressure in Patients with Stage I or II Hypertension. (2016) (1)
- Abstract 19408: Multiple Biomarker Approach Predicts Increasing Risk of Recurrent CV Events in Patients With Diabetes Mellitus in the EXAMINE Randomized Trial (2016) (1)
- B027: Is the safety of verapamil for patients with hypertension and angina affected by age? results from 1415 patients on COER-verapamil (2000) (1)
- Reproducibility of the nocturnal decline in blood pressure and the dipper and nondipper profile in essential hypertensive subjects (1999) (1)
- Response to Letter to the Editor by Blankfield regarding "Assessment of drug-induced increases in blood pressure during drug development: report from the Cardiac Safety Research Consortium.". (2013) (1)
- Rapid left ventricular filling is more dependent on age and twenty-four-hour blood pressure than on cardiac size. (1989) (1)
- AMELIORATION OF HYPERTENSION IN PATIENTS WITH TYPE 2 DIABETES — (2007) (1)
- Abstract 17295: Cardiovascular Biomarkers and Long-term Outcomes in Patients with Type 2 Diabetes Mellitus Treated with Alogiptin vs. Placebo in the EXAMINE Trial (2014) (1)
- Saxagliptin, alogliptin, and cardiovascular outcomes. (2014) (1)
- Patiromer vs. Placebo to Enable Spironolactone in Patients with Resistant Hypertension and Chronic Kidney Disease (AMBER): Results in Prespecified Subgroups (2019) (1)
- Receiver operating characteristics of home blood pressure measurements thatbest detect ambulatory hypertension (2004) (1)
- The Silver Anniversary of Blood Pressure Monitoring. (2020) (1)
- Long-term haemodynamic effects of amlodipine at rest and during exercise in essential hypertension. (1991) (1)
- for High Blood Pressure Research From the American Heart Association Professional Education Committee of the Council Resistant Hypertension: Diagnosis, Evaluation, and Treatment : A Scientific Statement (2013) (1)
- Hypertension & related disorders (2003) (1)
- Home Monitoring of Blood Pressure (2012) (1)
- Normal-Appearing Captopril MAG-3 Renal Scintigraphy in Hemodynamically Significant Renal Artery Stenosis (1995) (1)
- EARLY VERSUS LATE CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ACUTE CORONARY SYNDROME: INSIGHTS FROM THE EXAMINE TRIAL (2017) (1)
- P-425a: Hypertension reduction by device-guided breathing has a dose-response relationship (2002) (1)
- Ambulatory Blood Pressure Monitoring Can a Clinical Role Be Defined (1993) (1)
- SARCOMA OF THE MASTOID (1927) (1)
- Leadership message: strategic changes to preserve but enhance the American Society of Hypertension (2014) (1)
- Ambulatory Blood Pressure Monitoring in Clinical Trials of Drugs and Devices (2016) (1)
- Body weight changes in patients with type 2 diabetes and a recent acute coronary syndrome: an analysis from the EXAMINE trial (2021) (1)
- Sustained glucocorticoid tapering in the phase 3 trials of anifrolumab: a post hoc analysis of the TULIP-1 and TULIP-2 trials (2022) (1)
- C037: Reproducibility of ambulatory blood pressure in hemodialysis patients (2000) (1)
- O-59: Preventing early-morning blood pressure and rate-pressure product excesses in patients with hypertension (2001) (1)
- Heart rate and the rate-pressure product in patients with hypertension : the usefulness of chronotherapy (1999) (1)
- Impact of NSAIDs on cardiovascular risk and hypertension (2011) (1)
- AVERAGE CLINICIAN MEASURED BLOOD PRESSURE PREDICT CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES FOLLOWING ACUTE CORONARY SYNDROMES IN THE EXAMINE TRIAL (2017) (1)
- Circadian variation in cardiovascular events among diabetics in the convince trial (2004) (1)
- PATIROMER VS PLACEBO TO ENABLE SPIRONOLACTONE IN PATIENTS WITH RESISTANT HYPERTENSION AND CKD: ANALYSIS ACCORDING TO PATIENT SEX (AMBER TRIAL) (2021) (0)
- Ambulatory monitoring of the blood pressure in evaluating hypertensive patients (1995) (0)
- D24 - A chronotherapeutic approach to antihypertensive therapy: Nocturnal dosing of a novel delivery system of verapamil (1995) (0)
- Wednesday, May 16, 7:00 AM to 9:00 AM Aldosterone - A Common Link in Cardiac and Vascular Disorders*: Ability to selectively interfere with the effects of aldosterone in patients with hypertension and vascular disease (2001) (0)
- Response to Letter to Regarding Article, “Effects of Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase 2 Trial” (2012) (0)
- Board of Directors and Membership Benefits (2010) (0)
- Exclusion of non-responses (1996) (0)
- Board of Directors and Membership Benefits (2011) (0)
- Response to a New Hormone Therapy With Drospirenone and NO Production in Postmenopausal Women (2006) (0)
- C044: “Napping” is frequent in hypertensive subjects undergoing ambulatory blood pressure monitoring (1998) (0)
- P-247: The effect of COX-2 specific inhibitors on blood pressure control in patients with osteoarthritis and hypertension (2002) (0)
- Board of Directors and Membership Benefits (2011) (0)
- 20. Major Cardiovascular Outcomes in the EXAMINE Trial According to ACE Inhibitor Use (12-OR) (2015) (0)
- Individual patient risk assessment and cost–benefit analysis of patiromer in AMBER – Authors' reply (2020) (0)
- SAT-038 Ambulatory Blood Pressure Increases in Hypogonadal Men Who Develop Increases in Hematocrit on Oral Testosterone Undecanoate (2020) (0)
- Board of Directors and Membership Benefits (2011) (0)
- Clinically relevant drug-drug interactions of the PDE5 inhibitors (2005) (0)
- Chapter 7 – Ambulatory Blood Pressure Monitoring in Hypertension (2007) (0)
- Methods to Protect from Skeletal Cardiovascular Insufficiency: Improving Soldier Performance in Adverse Environments (2006) (0)
- Treating Pain and Inflammation in Hypertension (2012) (0)
- P-186: Importance of formulae used to calculate body surface area in determining left ventricular mass index (2002) (0)
- Foreword. The 20th year of Blood Pressure Monitoring. (2015) (0)
- Oral Sessions (2009) (0)
- P-353: A novel hormonal therapy with antihypertensive activity for postmenopausal women: drospirenone with estradiol (angeliq) (2004) (0)
- EXAMINE: targeting risk and treatment in diabetes – Authors' reply (2015) (0)
- Urinary cotinine and normetanephrine levels predict the ambulatory rate-pressure product in cigarette smokers (2014) (0)
- T04-P-037 Effects of novel aldosterone antagonist hormone therapy drospirenone/E2 on blood pressure and potassium in high risk hypertensive postmenopausal women (2005) (0)
- Board of Directors and Membership Benefits (2011) (0)
- Board of Directors and Membership Benefits (2011) (0)
- Severe circadian hypertension in a young man. (2011) (0)
- F4Outcome of a formulary policy switch for dihydropyridine calcium channel blocker therapy at A V.A medical center. (1995) (0)
- Tuesday, May 15, 5:00 PM to 7:00 PM Disruption of Renin-Angiotensin System: Future Directions*: Patterns of blood pressure responses: Day and night variations* (2001) (0)
- P-266: Comparison of nisoldipine ER versus amlodipine for the treatment of African-American patients with hypertension (2003) (0)
- Effect of Bremelanotide on Ambulatory Blood Pressure When Administered for Up to 16 Consecutive Days [14B] (2020) (0)
- Vascular disease and the renin-angiotensin system in the patient with hypertension: panel discussion and questions from the audience. (2000) (0)
- Comments on the study of Zannad et al. Monitoring to evaluate antihypertensive therapy. (1997) (0)
- [Clinical value of ambulatory monitoring of blood pressure]. (1998) (0)
- Efficacy of azilsartan medoxomil with chlorthalidone in (2014) (0)
- Editorial ''Translational'' medicine: transforming SPRINT findings into clinical practice (2016) (0)
- Impact of Androgen Deprivation Therapy on Cardiovascular Outcomes in Prostate Cancer (2022) (0)
- H27: The effects of antihypertensive therapy on nocturnal blood pressure: Nondippers vs dippers (1997) (0)
- Integrated Cardiovascular Safety Profile of Droxidopa (P5.126) (2016) (0)
- A large-scale ambulatory blood pressure monitoring (ABPM) trial in the practice setting: efficacy of the angiotensin receptor blocker, telmisartan (2004) (0)
- Antihypertensive Drugs and Pharmacology (2007) (0)
- The Present and Future of the American Society of Hypertension—2012 (2012) (0)
- Board of Directors and Membership Benefits (2008) (0)
- OR-62: Improving the definition and reproducibilty of nocturnal hypertension: absolute sleep blood pressure versus dipping proportion (2002) (0)
- Azilsartan Medoxomil for Treating Hypertension - Clinical Implications of Recent Trials (2011) (0)
- SUSTAINED ANTIHYPERTENSIVE ACTIVITY OF TELMISARTAN VS VALSARTAN: P 724 (2004) (0)
- Board of Directors and Membership Benefits (2011) (0)
- P-185: Body mass index and left ventricular mass are the best independent predictors of left atrial dimension (2002) (0)
- Diagnostic Evaluation for Patients With Renovascular Hypertension (2004) (0)
- The forgotten significance of heart rate in cardiovascular disease : implications of chronotherapeutics : proceedings of a satellite symposium held at the XXth congress of the European Society of Cardiology, Vienna, Austria, 22 August 1998 (1999) (0)
- Smoking Reduction Among Current Smokers and Cause-Specific Mortality: The NHLBI Pooled Cohorts Study (2020) (0)
- Board of Directors and Membership Benefits (2012) (0)
- REPORTS ON HYPERTENSION Improved Left Ventricular Filling Accompanies Reduced Left Ventricular Mass During Therapy of Essential Hypertension (2010) (0)
- P-572: Sodium intake in elderly hypertensives and outpatient compliance with low sodium diet (2005) (0)
- 11 – Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management (2018) (0)
- Module 1: Historical review of evidence-based treatment of hypertension. (2012) (0)
- Chapter 6 – Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management (2013) (0)
- Epidemiology (2007) (0)
- P-447: Can a long half-life angiotensin II blocker have greater effects on the circadian variation of blood pressure? (2003) (0)
- Benefits of DPP-4 Inhibitors in Patients with Type 2 Diabetes and Cardiovascular Risk (2013) (0)
- Panel Discussion 2 (1996) (0)
- Severe and resistant hypertension in an older woman with claudication. (2017) (0)
- Myocardial apoptosis in a heterotopic murine heart transplant model of chronic rejection/graft vasculopathy (1996) (0)
- H28 Effects of chronotherapy versus conventional antihypertensive therapy on the circadian variation of blood pressure and heart rate (1997) (0)
- Design and methods for the evaluation of Eprosartan in patients with isolated systolic hypertension (1999) (0)
- Ambulatory blood pressure monitoring. (1993) (0)
- PD66-11 EFFECTS OF VIBEGRON ON AMBULATORY BLOOD PRESSURE IN PATIENTS WITH OVERACTIVE BLADDER: RESULTS FROM A DOUBLE-BLIND STUDY (2021) (0)
- EFFECTS OF THE CYCLOOXYGENASE INHIBITING NITRIC OXIDE DONATOR NAPROXCINOD VERSUS NAPROXEN AND IBUPROFEN ON 24-HOUR BP IN PATIENTS WITH OSTEOARTHRITIS AND HYPERTENSION: PP.33.295 (2010) (0)
- Is Ambulatory Blood Pressure Monitoring Required to Define the Hypertensive Patient and to Detect Efficacy (1990) (0)
- E081: Heart rate response in the early morning hours (6am–12n) to chronotherapy and homeostatictherapy in patients with hypertension or in patients with myocardial ischemia (1998) (0)
- P-276: Automated versus operator directed diameter measurements for endothelial function in hypertensive patients (2002) (0)
- AZILSARTAN MEDOXOMIL/CHLORTHALIDONE FIXED-DOSE COMBINATION LOWERS BP MORE THAN OLMESARTAN/HYDROCHLOROTHIAZIDE FIXED-DOSE COMBINATION IN STAGE 2 SYSTOLIC HYPERTENSION: LB3.4 (2011) (0)
- Board of Directors and Membership Benefits (2010) (0)
- Preparing for Responsible Sharing of Clinical Trial Data (2014) (0)
- Management of hypertension in patients with enhanced cardiovascular risk. Introduction. (2008) (0)
- Evaluation of the Relationship Between Serum Urate Levels, Clinical Manifestations of Gout, and Death From Cardiovascular Causes in Patients Receiving Febuxostat or Allopurinol in an Outcomes Trial (2022) (0)
- discuss use of pulse wave velocity , central aortic pressure in reducing CV risk stratification (0)
- The antihypertensive agents: clinical pharmacology and therapeutic monitoring. (1987) (0)
- Importance of gender and age in assessing the 24-hour blood pressure response to antihypertensive therapy (1999) (0)
- Abstract 12845: Renal Biomarkers Predict Long-Term Adverse Events in Patients With Type 2 Diabetes Mellitus and Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial (2016) (0)
- 1054-P: Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and Chronic Kidney Disease (AMBER): Results in the Prespecified Subgroup with Diabetes (2020) (0)
- Effects of telmisartan 80 mg and valsartan 160 mg on ambulatory blood pressure in patients with essential hypertension. (2004) (0)
- Analysis of the Incidence of Supine Hypertension with Droxidopa (P5.127) (2016) (0)
- P-48: Home blood pressure but not office blood pressure predicts ambulatory blood pressure in patients with white-coat hypertension* (2001) (0)
- Message from the President of the American Society of Hypertension: The Journal of the American Society of Hypertension (JASH) will be the only official Journal of the Society in 2014 (2014) (0)
- EFFICACY AND SAFETY OF AZILSARTAN MEDOXOMIL/CHLORTHALIDONE WITH OLMESARTAN/HYDROCHLOROTHIAZIDE COMBINATIONS IN STAGE 2 SYSTOLIC HYPERTENSION: 4A.09 (2011) (0)
- Safety and Tolerability of Edivoxetine for Long-Term Treatment of Major Depressive Disorder in Adult Patients (2014) (0)
- Effects of Oral Testosterone Undecanoate (Kyzatrex) Versus Testosterone Gel (Androgel) on Long-Term (to 12 Months) Blood Pressure Levels (2022) (0)
- Reliability and practical value of automated blood pressure monitoring (1995) (0)
- Impact of smoking cessation on awake and sleep blood pressure and heart rate in women (2000) (0)
- CARDIOVASCULAR EVENTS IN PATIENTS RECEIVING ROFLUMILAST: FINDINGS FROM A POOLED ANALYSIS OF 14 RANDOMIZED CLINICAL TRIALS INVOLVING OVER 12,000 PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2011) (0)
- Compartment syndrome after anti-shock trouser application without lower-extremity trauma (1983) (0)
- Aldosterone Antagonism and Arterial Stiffness (2004) (0)
- Board of Directors and Membership Benefits (2011) (0)
- The impact of NSAIDs and COX-2 inhibitors on blood pressure control (2005) (0)
- Abstract 13272: Efficacy and Safety of Non-invasive Renal Denervation Study Using Externally Delivered Focused Ultrasound in Severe Resistant Hypertension (2015) (0)
- Board of Directors and Membership Benefits (2011) (0)
- Impact of timing of randomization after an acute coronary syndrome and subsequent events in patients with type 2 diabetes mellitus: an analysis of the EXAMINE trial (2020) (0)
- Board of Directors and Membership Benefits (2011) (0)
- Research Article Effectiveness of the selective aldosterone blocker, eplerenone, in patients with resistant hypertension (2008) (0)
- Abstract 15319: N-Terminal-pro-Brain Natriuretic Peptide Decreases Following Treatment with Alogliptin in Patients with Type 2 Diabetes and Recent Acute Coronary Syndromes: Results from EXAMINE (2014) (0)
- Physicians Guide to Hypertension (1990) (0)
- The results of this analysis also suggest the potential benefit of roflumilast on CV outcomes. Potential CV benefits of roflumilast should be evaluated in future controlled clinical trials. (2013) (0)
- Board of Directors and Membership Benefits (2012) (0)
- Board of Directors and Membership Benefits (2012) (0)
- The influence of electronically-measured physical activity of ambulatory blood pressure, heart rate, and the rate pressure product. (1999) (0)
- P-670: Effects of novel hormone therapy with aldosterone antagonist activity drospirenone/estradiol on blood pressure, renal function, and potassium in high risk subgoups of hypertensive postmenopausal women (2005) (0)
- Table of Contents Renin-Angiotensin Aldosterone System and Hypertension : Current Approaches and Future Directions (2007) (0)
- Acute Versus Chronic Dosing Studies (1996) (0)
- In older people with systolic hypertension, office but not home BP correlates with ambulatory BP and white matter hyperintensity lesions (2015) (0)
- Factors in the choice of beta-blocker vs. diuretic for initial treatment of hypertension in convince (2004) (0)
- Board of Directors and Membership Benefits (2010) (0)
- Wednesday, May 19, Broadway Ballroom South, 1:00 PM to 3:30 PM: What have we learned from ambulatory blood pressure monitoring research during the past five years?What have we learned from ambulatory blood pressure monitoring research during the past five years? (1999) (0)
- J7: Circadian blood pressure variation in patients with primary hyperparathyroidism is normal (1997) (0)
- Board of Directors and Membership Benefits (2010) (0)
- Cardiovascular Effects of NSAIDS (2019) (0)
- Home Blood Pressure Monitoring in Clinical Research (2019) (0)
- The present and future of the American Society of Hypertension: 2012. (2012) (0)
- Effects Of Chronotherapeutic Delivery of Verapamil In Obese Vs Non‐obese Patients With Hypertension (1999) (0)
- P-600: Primary aldosteronism with and without hypertensive urgency : Clinical and biochemical features (2003) (0)
- Cardiovascular Safety of Roflumilast: Response (2013) (0)
- P-253: Development of clinically significant systolic hypertension for the COX-2 selective inhibitor valdecoxib is similar to placebo and conventional NSAIDs in hypertensive patients with chronic arthritis (2005) (0)
- P-47: The relationship of office and ambulatory systolic blood pressures and pulse pressures to cardiac structural parameters in never treated hypertensive subjects (2003) (0)
- ASH Position Article When and how to use self (home) and ambulatory blood pressure monitoring (2010) (0)
- C041: Poor sleep quality among hypertensive patients may cause a nondipper circadian blood pressure profile (2000) (0)
- SO033PATIROMER TO ENABLE SPIRONOLACTONE IN PATIENTS WITH RESISTANT HYPERTENSION AND CHRONIC KIDNEY DISEASE (AMBER): PRESPECIFIED RESULTS BY BASELINE SERUM POTASSIUM (2020) (0)
- Matching the circadian rhythms of hypertension with pharmacotherapy (2003) (0)
- Value of ambulatory BP versus office BP in predicting left ventricular mass index in untreated African-American hypertensives. (1999) (0)
- and Management of Patients With Hypertension Expanding the Use of Ambulatory Blood Pressure Monitoring for the Diagnosis (2006) (0)
- Panel discussion among Drs Glasser, Mulcahy, Muller, Opie, White and Zanchetti (1998) (0)
- K028: Prediction of interdialytic ambulatory blood pressure in 91 hemodialysis patients (2000) (0)
- Cross-over versus sequential study design (1996) (0)
- Board of Directors and Membership Benefits (2010) (0)
- Board of Directors and Membership Benefits (2010) (0)
- Sustained antihypertensive activity of telmisartan vs valsartan (2004) (0)
- Wednesday, May 13, Broadway Ballroom South, 10:30 AM: Modern Evaluation of the Hypertensive PatientCircadian variation of blood pressure in the assessment of pharmacologic therapy for hypertension – the CESNA and TIMED trials (1998) (0)
- P-165: Terminal digit bias in blood pressure measurement is reduced but not eliminated in a specialist hypertension practice (2002) (0)
- Blood Pressure Measurement in Older Patients With Hypertension (2005) (0)
- Chronotherapy is less likely than homeostatic therapy to induce low sleep systolic blood pressure in patients with hypertension (1998) (0)
- Measurement of Trough Blood Pressure (1996) (0)
- Response to Letter Regarding Article, "Effects of Intensive Versus Standard Ambulatory Blood Pressure Control on Cerebrovascular Outcomes in Older People (INFINITY)". (2020) (0)
- Small Vessel Disease of the Brain and Stroke: Association with Clinic and Ambulatory Blood Pressure (2016) (0)
- Effects of drospirenone/estradiol on blood pressure and serum potassium in hypertensive postmenopausal women at risk for hyperkalemia (2004) (0)
- P-184: Impact of ambulatory blood pressure criteria for white coat hypertension on cardiac structure in a biracial population in Connecticut (2002) (0)
- Contribuição Internacional Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate (2001) (0)
- Acute pain in the tip of the index finger. (2005) (0)
- FIXED-DOSE COMBINATION OF AZILSARTAN MEDOXOMIL/CHLORTHALIDONE PROVIDES SUPERIOR BP REDUCTION TO MONOTHERAPIES IN STAGE 2 HYPERTENSION: PP.14.382 (2011) (0)
- Blood Pressure Monitoring enters its 14th year. (2009) (0)
- 21. Cardiac Ischemic Outcomes and Hospitalizations in Patients with Type 2 Diabetes and Recent Acute Coronary Syndrome Treated with Alogliptin or Placebo: New Insights from the EXAMINE Trial (13-OR) (2015) (0)
- P-245: Differential effects of COX-2 inhibitors on systolic blood pressure in hypertensive patients treated with ACE inhibitors and beta-blockers versus calcium antagonists (2002) (0)
- Department of Error (2020) (0)
- Transdermal clonidine in a patient with resistant hypertension and malabsorption. (1985) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With William Beverly White?
William Beverly White is affiliated with the following schools:
